Paclitaxel (PTX), a definited drug with anti-tumor effect, has been employed in treating various kinds of cancer. However, clinical effects have been hampered by its poor solubility and serious side effects. In this work, we developed an albumin-polymer liposome system for delivering PTX. Maleimide (MI) was employed to facilitate PTX binding with albumin, and liposome was comprised with lecithin and cholesterol. The albumin-bound PTX liposome system exhibited a high encapsulation efficiency, excellent drug load and good particle size. Combination of albumin and liposome, this system has the property to target in tumor issues and PTX could be released in tumor microenvironment by breaking the hydrazone bond to exhibit antitumor activity.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.